Font Size:
a
A
A
Keyword [immune checkpoint inhibitor]
Result: 81 - 91 | Page: 5 of 5
81.
Incidence And Risk Factors Of Lung Injury In Patients With Advanced Malignant Tumor Treated With PD-1 Immune Checkpoint Inhibitor
82.
Analysis Of The Efficacy And Safety Of Immune Checkpoint Inhibitors Combined With Anti-angiogenesis Targeted Drugs Compared To Sorafenib As First-line Treatment For Unresectable Hepatocellular Carcinom
83.
Efficacy And Safety Of ICIs In Lung Cancer Patients With Concomitant ILD: A Meta-analysis Of Observational Studies
84.
Molecular Subtype And Immunotherapy Evaluation Of Bladder Cancer Based On Hypoxia-related Genes
85.
Preliminary Study On Evaluation Of Immune Testicular Injury Induced By PD-1 Inhibitor In Rabbits By Two-dimensional Shear Wave Eastography
86.
Application Of Immune Checkpoint Inhibitors In The Treatment Of Advanced Pancreatic Cancer
87.
Short-term Clinical Observation And Meta Analysis Of Efficacy And Safety Of PD-1 Inhibitor Combined With Anlotinib In Second-line Treatment Of Advanced Esophageal Squamous Cell Carcinoma
88.
Study On Supportive Care Needs And Influencing Factors In Patients With Lung Cancer Treated With Immune Checkpoint Inhibitor
89.
Study On The Current Status And Influencing Factors Of Symptom Burden In Patients With Lung Cancer Treated With Immune Checkpoint Inhibitor
90.
Echocardiographic Two-dimensional Speckle Tracking Strain Technique For Risk Stratification And Prognosis Of Patients With Immune Checkpoint Inhibitor-related Myocarditi
91.
Construction Of Atezolizumab-modified Nanoparticles Loaded With Dihydrotanshinone I And Study Of Its Anti-tumor Effec
<<First
<Prev
Next>
Last>>
Jump to